Share Buyback

Immunodiagnostic Systems Holdings PLC

4 September 2018

Immunodiagnostic Systems Holdings plc

Completion of Share Buyback

Immunodiagnostic Systems Holdings PLC ('IDS' or 'the Company'), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, today announcesthat further to the proposed share buyback announcement on 30 August 2018 the Company has acquired 600,000 ordinary shares of 0.2p ('Ordinary Shares') at 220 pence per Ordinary Share. All Ordinary Shares purchased under the share buyback will be held in Treasury.

Total Voting Rights

The Company's issued share capital comprises 29,450,175 Ordinary Shares. Of these 666,078 are held in Treasury. The total voting rights of the Company are 28,784,097 Ordinary Shares and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information:

Immunodiagnostic Systems Holdings plc

Tel : +44 (0)191 5190660

Jaap Stuut, Chief Executive Officer

Paul Martin, Group Finance Director

Peel Hunt LLP

Tel : +44 (0)207 418 8900

James Steel

Oliver Jackson

Sohail Akbar (ECM)

Attachments

  • Original document
  • Permalink

Disclaimer

IDS - Immunodiagnostic Systems Holdings plc published this content on 04 September 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 04 September 2018 07:06:06 UTC